LONDON: A US$93bil plunge in Novo Nordisk A/S shares has provided the latest blow to Europe’s largest listed companies, which ...

Novo Nordisk and Eli Lilly are currently a duopoly in the obesity market, which reached a value of $24 billion last year ...

Lilly investors got the jitters, saw better opportunities elsewhere, or decided to hold onto their chips. In the third ...

Prothena's stock soared 34% despite setbacks, with promising partnerships and potential in Parkinson's and Alzheimer's ...

Watch out, Eli Lilly and Novo Nordisk. Merck (NYSE: MRK) is hungrily looking to take a bite out of the weight-loss drugs ...

A $93 billion plunge in Novo Nordisk A/S shares has provided the latest blow to Europe’s largest listed companies, which have ...

Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with ...

Volkswagen on Friday announced sweeping changes to its German operations, including more than 35,000 future job cuts and ...